XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows
$ in Millions
 12 Months Ended
Dec. 28, 2024
USD ($)
Dec. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Operating Activities:      
Net earnings (loss) $ 294.3 $ (310.5) $ 1,062.7
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization of property, plant and equipment 426.3 432.4 369.7
Amortization of intangibles 163.2 192.7 202.5
Inventory step-up amortization 0.0 0.0 80.3
Loss on sales of businesses 0.0 10.8 8.4
(Gain) loss on sale of discontinued operations (10.4) 14.3 (1,197.4)
Asset impairment charges 72.4 274.8 168.4
Stock-based compensation expense 105.4 83.8 90.7
Provision for credit losses 22.2 8.7 30.0
Deferred tax benefit (227.2) (424.3) (271.7)
Other non-cash items 186.3 154.5 72.1
Changes in operating assets and liabilities:      
Accounts receivable 58.2 (117.0) 109.0
Inventories 93.0 906.6 (792.4)
Accounts payable 173.3 (23.0) (991.4)
Deferred revenue (3.0) 2.4 (29.9)
Other current assets 7.1 115.6 15.6
Other long-term assets (49.7) (175.7) (351.3)
Accrued expenses (230.5) (25.6) (176.3)
Defined benefit liabilities (40.9) (42.2) (31.9)
Other long-term liabilities 66.9 113.0 173.4
Net cash provided by (used in) operating activities 1,106.9 1,191.3 (1,459.5)
Investing Activities:      
Capital and software expenditures (353.9) (338.7) (530.4)
Sales of assets 14.8 15.1 41.7
Business acquisitions, net of cash acquired 0.0 0.0 (71.9)
Sales of businesses, net of cash sold 735.6 (5.7) 4,147.1
Net investment hedge settlements 0.0 0.0 10.6
Other (2.3) 1.6 (24.5)
Net cash provided by (used in) investing activities 394.2 (327.7) 3,572.6
Financing Activities:      
Proceeds from debt issuances, net of fees 0.0 745.3 992.6
Net short-term commercial paper repayments (1,056.9) (1,044.7) (138.1)
Stock purchase contract fees 0.0 0.0 (39.4)
Credit facility borrowings 0.0 0.0 2,500.0
Credit facility repayments 0.0 0.0 (2,500.0)
Purchases of common stock for treasury (17.7) (16.1) (2,323.0)
Proceeds from issuance of remarketed preferred stock 0.0 0.0 750.0
Redemption and conversion of preferred stock 0.0 0.0 (750.0)
Proceeds from issuances of common stock 24.8 19.0 38.7
Craftsman contingent consideration payments 0.0 (18.0) (41.3)
Termination of interest rate swaps 0.0 0.0 22.7
Cash dividends on common stock (491.2) (482.6) (465.8)
Cash dividends on preferred stock 0.0 0.0 (5.8)
Other (15.7) (18.9) (11.7)
Net cash used in financing activities (1,556.7) (816.0) (1,971.1)
Effect of exchange rate changes on cash and cash equivalents (106.2) 2.1 (31.9)
Change in cash, cash equivalents and restricted cash (161.8) 49.7 110.1
Cash, cash equivalents and restricted cash, beginning of year 454.6 404.9 294.8
Cash, cash equivalents and restricted cash, end of year 292.8 454.6 404.9
Supplemental Cash Flow Information [Abstract]      
Cash and cash equivalents 290.5 449.4  
Restricted cash included in Other current assets 2.3 4.6  
Cash and cash equivalents included in Current assets held for sale 0.0 0.6  
Cash, cash equivalents and restricted cash $ 292.8 $ 454.6 $ 404.9